Drug Trial Radar · NCT06225973
A Study of TL-925 Ophthalmic Emulsion as a Treatment for Dry Eye Disease
Last checked: Nov 19, 2026Latest source record: Jul 10, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
880
Planned (sponsor's estimate)
Start
Feb 6, 2024
Primary completion
Dec 2024
Study completion Dec 2024
Sponsor
- Lead sponsor
- Telios Pharma, Inc.Industry
- Sponsor type
- Industry
- First posted
- Jan 26, 2024
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
In this prospective, phase 2b, multicenter, randomized, double-masked, vehicle-controlled, parallel-arm study, approximately 880 subjects with moderate to severe dry eye disease (DED) will be randomly assigned (1:1) to receive either TL-925 or vehicle as topical ophthalmic eye drops administered bilaterally BID. The study will comprise two phases: a two-week screening phase/run-in and a six-week double-masked treatment phase.
Conditions
- Dry Eye Disease
Interventions
TL-925Drug
TL-925 is an eye drop.
PlaceboOther
The composition of the vehicle is identical to the active formulation except for the exclusion of the active ingredient.
Primary outcomes
What the sponsor says the trial is designed to measure.
- To evaluate the efficacy of TL-925 compared to vehicle on tear productionTime frame: Baseline to Day 29
Locations
18 sites in 1 country. Site status is shown where the registry gives one.
Cornea and Cataract Consultants of Arizona
Phoenix, Arizona
Global Research Management
Glendale, California
Nvision - La Mesa
La Mesa, California
Nvision - Torrance
Torrance, California
Wyse Eyecare
Northbrook, Illinois
Pankratz Eye
Columbus, Indiana
Butchertown Clinical
Louisville, Kentucky
Andover Eye Associates - Andover
Andover, Massachusetts
Andover Eye Associates - Raynham
Raynham, Massachusetts
NEERA - Westborough
Westborough, Massachusetts
NEERA - Woburn
Woburn, Massachusetts
Oculus Research
Garner, North Carolina
Wilmington Eye
Leland, North Carolina
Scott and Christie EyeCare Associates
Cranberry Township, Pennsylvania
Advancing Vision Research
Goodlettsville, Tennessee
Total Eye Care, PA
Memphis, Tennessee
Advancing Vision Research
Smyrna, Tennessee
Piedmont Eye Center
Lynchburg, Virginia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.